George Homa
General Practice · Bridgeport, PANPI 1316932890
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 388 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,869 and has fallen 96.0% since, to $115 in 2025. Among general practice clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 388 payments — averaging $20.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$971
- Pfizer$933
- Novo Nordisk$692
- Lilly USA, LLC$675
- Merck$507
- Amarin Pharma, Inc.$403
- plus $4K from 26 others
What the payments were for
- Speaking & faculty fees$461%
- Food & beverage$7,74198%
- Education$1482%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 45 | $971 |
| Pfizer | 63 | $933 |
| Novo Nordisk | 30 | $692 |
| Lilly USA, LLC | 31 | $675 |
| Merck | 44 | $507 |
| Amarin Pharma, Inc. | 26 | $403 |
| Astellas Pharma US Inc | 17 | $379 |
| AbbVie(2 entities) | 21 | $303 |
| GSK | 13 | $301 |
| Boehringer Ingelheim | 15 | $283 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 16 | $239 |
| Johnson & Johnson | 9 | $219 |
| Amgen | 9 | $218 |
| Kowa Pharmaceuticals America, Inc. | 15 | $201 |
| Biohaven Pharmaceuticals, Inc. | 4 | $167 |
| Acorda Therapeutics, Inc | 3 | $163 |
| Zimmer Biomet | 1 | $136 |
| Biocryst US Sales Co., LLC | 1 | $115 |
| Mallinckrodt Hospital Products Inc. | 1 | $115 |
| Phathom Pharmaceuticals, Inc. | 1 | $115 |
| Valeritas, Inc. | 1 | $114 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $113 |
| Eisai Inc. | 5 | $107 |
| Insmed, Inc. | 1 | $106 |
| Sanofi-aventis U.S. LLC | 1 | $104 |
| Daiichi Sankyo Inc. | 4 | $69 |
| Sanofi Pasteur Inc. | 3 | $62 |
| E.r. Squibb & Sons, L.L.C. | 2 | $42 |
| Hikma Pharmaceuticals USA | 2 | $24 |
| Nestle Healthcare Nutrition Inc. | 1 | $22 |
| Almatica Pharma LLC | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,936 in reported general payments places this provider in the 95th percentile of 3,208 general practice providers in Pennsylvania.
Other general practice in Bridgeport
- Corey AnolikPhiladelphia$2.1M
- Richard NagelbergPlymouth Meeting$1.4M
- Alan AtlasPhiladelphia$486K
- Susan McMahonPittsburgh$364K
- Carl MedgausMonroeville$192K
- Yooson KimMorgantown$166K
- Michael WollockArdmore$113K
- Marc ManosPhiladelphia$85K
- Michele ColumboBryn Mawr$79K
- Robert MarusYardley$77K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.